Pricing Log in Create free account

Bicycle Therapeutics PLC Sponsored ADR (BCYC) vs PepGen, Inc. (PEPG)

Bicycle Therapeutics PLC Sponsored ADR and PepGen, Inc. are both Biotechnology companies. Bicycle Therapeutics PLC Sponsored ADR and PepGen, Inc. are of similar size ($181.4M and $175.2M). PepGen, Inc. has the higher net margin (0.00% vs −311.1%) and the higher return on invested capital (−2,076.3% vs −64,747.5%). Across the 13 metrics below, PepGen, Inc. leads on 9 and Bicycle Therapeutics PLC Sponsored ADR on 4.

Valuation

Metric BCYC PEPG Biotechnology median
P/E n/m n/m 8.50
P/S 3.95 n/m 9.71
P/B 0.47 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.21 n/m 0.64
EV/Sales (4.04) n/m 9.21
Earnings yield (78.90%) (50.38%) (33.15%)
Free cash flow yield (86.23%) (38.63%) (25.50%)

Profitability

Metric BCYC PEPG Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (343.60%) 0.00% 0.00%
Net margin (311.11%) 0.00% 0.00%
Free cash flow margin (340.29%) 0.00% 0.00%
Return on equity (32.30%) (75.45%) (56.36%)
Return on assets (26.47%) (59.06%) (48.04%)
Return on invested capital (64,747.54%) (2,076.25%) 0.00%

Growth

Metric BCYC PEPG Biotechnology median
Revenue growth (TTM) 217.44% — 6.02%
EPS growth (last fiscal year) (8.97%) 25.61% 30.26%
Revenue growth, 5-year CAGR 47.52% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCYC PEPG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.08 13.36 4.72
Net debt to EBITDA 2.61 1.64 0.96

Dividend

Metric BCYC PEPG Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCYC PEPG Biotechnology median
Market cap 181.37m 175.22m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack